RSS

Johnson & Johnson

The Janssen Pharmaceutical Companies of Johnson & Johnson has reported the positive topline results from the ATLAS Phase III study investigating a novel, long acting injectable two-drug regimen for the treatment of HIV-1. more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

Johnson & Johnson has launched a life sciences networking hub in Philadelphia to help accelerate healthcare innovation in the region. more

Technology

May and Trump

AL hutluht / Shutterstock.com

A black-tie dinner has been arranged for UK business leaders — including big pharma CEOs — and the US president, Donald Trump, to be hosted by the prime minister, Theresa May, according to an article published in the Financial Times (FT). more

News

The Janssen Pharmaceutical Companies of Johnson & Johnson has announced that the European Commission has granted marketing authorisation for Juluca (dolutegravir/rilpivirine) — a two-drug regimen, once-daily, single pill for the treatment of HIV-1. more

News

Swedish bioengineering company, Probi, has signed a long-term agreement with Cilag, which is a member of the Johnson & Johnson family of companies, for the development of a probiotic product. more

News

Biotech company, Proteros, has entered into a new research collaboration with Janssen Biotech (one of the Janssen Pharmaceutical companies of Johnson & Johnson) that is aimed at discovering novel lead compounds against several epigenetic targets more

News

Johnson & Johnson Innovation (J&J Innovation) and Janssen Research and Development have announced the launch of the World Without Disease QuickFire challenge for disease solutions from across the pharmaceutical, medical device and consumer sectors more

News

Pharmaceutical companies, including GSK, Merck, Pfizer and AstraZeneca have called on governments to create new ways of funding antibiotic development, according to the BBC more

News

Johnson & Johnson's Janssen Biotech is to deploy Emulate’s organs-on-chips platform to better predict the potential human response of drug candidates and improve the drug development process under a recently formed research collaboration. more

News

A collaboration to identify and accelerate drug candidates for the treatment and prevention of diseases with high unmet medical needs has been revealed by Lead Discovery Center (LDC) and Johnson & Johnson Innovation. more

News

Johnson and Johnson has posted its 2014 figures. While pharma sales saw healthy growth, the devices business was less encouraging. more

News

Johnson & Johnson has accelerated its Phase 1, first-in-human clinical trial of a preventive Ebola vaccine, with Chief Scientific Officer Paul Stoffels stating "every day counts". more

News

The vaccine regimen, which was discovered in a collaborative research program with the National Institutes of Health (NIH), combines a Janssen preventative vaccine with a vaccine from Bavarian Nordic, a biotechnology company based in Denmark. more

News

Three-year agreement will support research on treatments for major brain disorders. more

Talking head: According to Sandra Peterson, group worldwide chairman of Johnson & Johnson said: “One of the great exciting things that is happening is the understanding of biology and genomics." more

News

Talking head: According to Sandra Peterson, group worldwide chairman of Johnson & Johnson said: “One of the great exciting things that is happening is the understanding of biology and genomics." more

News